These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 27434676

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Long-Term Outcomes of Liver Transplantation in Patients With Pretransplant Renal Dysfunction Treated With Induction Therapy and Delayed Reduced De Novo Once-Daily Tacrolimus.
    Gastaca M, Prieto M, Palomares I, Bustamante J, Fernandez JR, Ruiz P, Ventoso A, Salvador P, Senosiain M, Testillano M, Suarez MJ, Valdivieso A.
    Transplant Proc; 2020 Jun; 52(5):1489-1492. PubMed ID: 32217015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A prospective, multicenter study of once-daily extended-release tacrolimus in de novo liver transplant recipients.
    Charco R, Caralt M, Lladó L, Valdivieso A, Fabregat J, Matarranz A, Gonzalez-Pinto I, Pardo F, Fábrega E, Bilbao I.
    Transplant Proc; 2011 Apr; 43(3):718-23. PubMed ID: 21486582
    [Abstract] [Full Text] [Related]

  • 7. Conversion From Twice-Daily to Once-Daily Tacrolimus Among Egyptian Living-Donor Kidney Allograft Recipients: A Single-Center Experience.
    Bakr MA, Nagib AM, Abbas MH, Donia AF.
    Exp Clin Transplant; 2019 Oct; 17(5):594-598. PubMed ID: 31050617
    [Abstract] [Full Text] [Related]

  • 8. Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience.
    Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K.
    Nephrology (Carlton); 2016 Oct; 21(10):821-7. PubMed ID: 26854648
    [Abstract] [Full Text] [Related]

  • 9. Once-daily prolonged-release tacrolimus in de novo liver transplantation: a single center cohort study.
    Marubashi S, Wada H, Kobayashi S, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H.
    Hepatogastroenterology; 2012 Jun; 59(116):1184-8. PubMed ID: 22172333
    [Abstract] [Full Text] [Related]

  • 10. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.
    Jain A, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl T, Fung J.
    Ann Surg; 1999 Sep; 230(3):441-8; discussion 448-9. PubMed ID: 10493490
    [Abstract] [Full Text] [Related]

  • 11. Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients.
    Dumortier J, Guillaud O, Boillot O.
    Liver Transpl; 2013 May; 19(5):529-33. PubMed ID: 23483701
    [Abstract] [Full Text] [Related]

  • 12. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG, Jiang L, Yang J.
    World J Gastroenterol; 2016 Feb 14; 22(6):2133-41. PubMed ID: 26877618
    [Abstract] [Full Text] [Related]

  • 13. Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
    Chapman WC, Brown RS, Chavin KD, Sudan D, Koneru B, Junge G, Dong G, Patel D, Teperman L, Fung JJ.
    Transplantation; 2017 Feb 14; 101(2):341-349. PubMed ID: 28121741
    [Abstract] [Full Text] [Related]

  • 14. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
    Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR.
    J Surg Res; 2007 Apr 14; 138(2):198-204. PubMed ID: 17292404
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.